Citius Pharmaceuticals
CTXR
CTXR
29 hedge funds and large institutions have $2.43M invested in Citius Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
79% less capital invested
Capital invested by funds: $11.8M → $2.43M (-$9.38M)
82% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 34
Holders
29
Holding in Top 10
–
Calls
$244K
Puts
$103K
Top Buyers
| 1 | +$110K | |
| 2 | +$93.2K | |
| 3 | +$51.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$32.2K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$31.7K |
Top Sellers
| 1 | -$3.64M | |
| 2 | -$143K | |
| 3 | -$141K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$107K |
| 5 |
WAS
Wealth Advisory Solutions
Indiianapolis,
Indiana
|
-$101K |